Clinical Trials Logo

Becker Muscular Dystrophy clinical trials

View clinical trials related to Becker Muscular Dystrophy.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06066580 Enrolling by invitation - Clinical trials for Becker Muscular Dystrophy

Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

MESA
Start date: November 2, 2023
Phase: Phase 2
Study type: Interventional

EDG-5506-203 MESA is an open-label extension study to assess the long-term effect of sevasemten (EDG-5506) on safety, biomarkers, and functional measures in adults and adolescents with Becker muscular dystrophy